MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 49 filers reported holding MARKER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22 | -99.9% | 84,068 | -16.0% | 0.00% | -50.0% |
| Q3 2022 | $37,000 | +12.1% | 100,068 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -17.5% | 100,068 | +11.1% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -32.2% | 90,068 | +44.0% | 0.00% | -33.3% |
| Q4 2021 | $59,000 | -50.0% | 62,568 | -10.7% | 0.00% | -50.0% |
| Q3 2021 | $118,000 | -39.5% | 70,068 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $195,000 | +24.2% | 70,068 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $157,000 | +53.9% | 70,068 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $102,000 | -29.2% | 70,068 | -27.1% | 0.01% | -35.7% |
| Q3 2020 | $144,000 | -36.8% | 96,165 | -12.7% | 0.01% | -36.4% |
| Q2 2020 | $228,000 | +71.4% | 110,174 | +57.2% | 0.02% | +37.5% |
| Q1 2020 | $133,000 | -28.9% | 70,068 | +7.7% | 0.02% | -5.9% |
| Q4 2019 | $187,000 | -35.3% | 65,068 | +15.0% | 0.02% | -39.3% |
| Q3 2019 | $289,000 | +77.3% | 56,568 | +175.7% | 0.03% | +75.0% |
| Q2 2019 | $163,000 | – | 20,520 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
| NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
| Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
| AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
| MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
| Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
| Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
| NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |